Hvis en patient udvikler tegn eller symptomer på malignt neuroleptikumsyndrom, bør alle antipsykotika, herunder INVEGA, seponeres.
If a patient develops signs or symptoms indicative of NMS, all antipsychotics, including INVEGA, should be discontinued.